Hot flashes are not predictive for serum concentrations of tamoxifen and its metabolites

BACKGROUND: Tamoxifen has dramatically reduced the recurrence and mortality rate of estrogen receptor positive breast cancer. However, the efficacy of tamoxifen varies between individuals and 40% of patients will have a recurrence despite adjuvant tamoxifen treatment. Factors that predict tamoxifen...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Jager, Nynke GL, Koornstra, Rutger HT, Vincent, Andrew D, van Schaik, Ron HN, Huitema, Alwin DR, Korse, Tiny M, Schellens, Jan HM, Linn, Sabine C, Beijnen, Jos H
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2013
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3880169/
https://ncbi.nlm.nih.gov/pubmed/24373320
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-612
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items